Steuber Thomas, Niemela Pauliina, Haese Alexander, Pettersson Kim, Erbersdobler Andreas, Felix Chun K-H, Graefen Markus, Kattan Michael W, Huland Hartwig, Lilja Hans
Department of Urology, University of Hamburg Eppendorf, Hamburg, Germany.
Prostate. 2005 Apr 1;63(1):13-8. doi: 10.1002/pros.20156.
We investigated the association of different subfractions of prostate specific antigen (PSA) and human glandular kallikrein 2 (hK2), such as total PSA (tPSA), complexed PSA (cPSA), free PSA (fPSA), "single-chain Intact fPSA" (fPSA-I), "multi-chain nicked fPSA" (fPSA-N), and total hK2 with volumes of total prostate gland, transition zone (tz), and prostate cancer (PCa) tissue in patients with benign and malignant prostatic disease.
Serum samples were collected from men with negative biopsy (n=164) and PCa (n=252). Total and fPSA were measured using a commercially immunoassay. We measured hK2 and fPSA-I by previously reported in-house research assays specific for hK2 and single-chain, non-cleaved fPSA, respectively. Levels of fPSA-N (=fPSA-fPSA-I) and cPSA (=tPSA-fPSA) were calculated. Total prostate and tz volume were measured using transrectal ultrasound (TRUS); PCa volume was calculated using a computer assisted volumetric program. Association with tz and cancer volumes (CaVols) was performed by linear regression analysis.
All PSA subfractions and hK2 were associated with tz volume in multivariable linear regression analysis. Only hK2, fPSA, and fPSA-N were significantly associated with CaVol in multivariable analysis, fPSA-I seemed to be cancer related.
The multi-chain fPSA-N subfractions of fPSA may be a valuable predictor of both benign prostate hyperplasia (BPH) and CaVol that is likely to be more useful in predicting tz volumes than CaVols. fPSA-I may provide information on cancer without being influenced by the presence of BPH.
我们研究了前列腺特异性抗原(PSA)和人腺体激肽释放酶2(hK2)的不同亚组分,如总PSA(tPSA)、复合PSA(cPSA)、游离PSA(fPSA)、“单链完整fPSA”(fPSA-I)、“多链切口fPSA”(fPSA-N)以及总hK2与良性和恶性前列腺疾病患者的前列腺总体积、移行区(tz)和前列腺癌(PCa)组织体积之间的关联。
收集活检阴性男性(n = 164)和前列腺癌患者(n = 252)的血清样本。使用商业免疫测定法测量总PSA和fPSA。我们分别通过先前报道的针对hK2和单链、未裂解fPSA的内部研究测定法测量hK2和fPSA-I。计算fPSA-N(=fPSA - fPSA-I)和cPSA(=tPSA - fPSA)的水平。使用经直肠超声(TRUS)测量前列腺总体积和tz体积;使用计算机辅助体积程序计算PCa体积。通过线性回归分析进行与tz和癌体积(CaVols)的关联分析。
在多变量线性回归分析中,所有PSA亚组分和hK2均与tz体积相关。在多变量分析中,只有hK2、fPSA和fPSA-N与CaVol显著相关,fPSA-I似乎与癌症相关。
fPSA的多链fPSA-N亚组分可能是良性前列腺增生(BPH)和CaVol的有价值预测指标,在预测tz体积方面可能比CaVols更有用。fPSA-I可能提供有关癌症的信息,而不受BPH存在的影响。